Source: Annual Congress 2005 - Tobacco smoking related health issues
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. André, F. Oliveira, R. Ferreira, H. Lucas, M. Raposo, M. C. Abreu (Lisbon, Portugal). Impairment of lung function in asymptomatic smokers. Eur Respir J 2005; 26: Suppl. 49, 1009

Member's Comments

No comment yet.

Related content which might interest you: Lung function impairment in young AAT-deficient smokers Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 Lung function impairment in smokers Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009 Regional lung function in nonsmokers and asymptomatic current and former smokers Source: ERJ Open Res, 5 (3) 00240-2018; 10.1183/23120541.00240-2018 Year: 2019 Small airway function and peripheral airway disease in healthy subjects and smokers Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Hyperhomocysteinaemia predicts the decline in pulmonary function in healthy male smokers Source: Eur Respir J 2013; 42: 18-27 Year: 2013 Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Small airway function in smokers without airway obstruction Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Arterial stiffness in symptomatic smokers with normal lung function Source: ERJ Open Res, 3 (3) 00037-2017; 10.1183/23120541.00037-2017 Year: 2017 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Lung function decline in patients with bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity Source: Eur Respir J 2015; 46: 1589-1597 Year: 2015 Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Impairment of mucociliary clearance in COPD and smokers: Same or different? Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002 Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers Source: ERJ Open Res, 2 (4) 00066-2016; 10.1183/23120541.00066-2016 Year: 2016 Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS Source: Eur Respir J, 54 (4) 1802214; 10.1183/13993003.02214-2018 Year: 2019 Decreased pulmonary mature dendritic cells in healthy smokers and smoking COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007 Small airways disease evaluation in healthy smokers with normal spirometry values Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019